Pharmaceutical Excipients Market Pharmaceutical Excipients Market size was valued at USD 9.48 billion in 2022 and is poised to grow from USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031). Pharmaceutical Excipients Market size was valued at USD 10.12 billion in 2023 […]
The major players operating in this market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), and Eppendorf AG (Germany), KUBOTA Corporation (Japan), Sigma Laborzentrifugen GmbH (Germany), NuAire (US) Browse 426 market data Tables and 55 Figures spread through 373 Pages and in-depth TOC on “Laboratory Centrifuges Market by Product (Equipment(Microcentrifuge, Ultracentrifuge), Accessories(Tube, Plate)), Model(Benchtop), […]
Dementia Drugs Market Dementia drugs companies working in the market include Apotex Inc, AstraZeneca, Aurobindo Pharma, Eisai Co., Ltd, Eli Lilly and Company, Johnson and Johnson, Pfizer, Inc., Teva Pharmaceuticals, Zydus Cadila, Janssen Pharmaceuticals, Inc., Biogen Pharmaceuticals, Forest Laboratories, Inc., Novartis AG, Sanofi S.A., AstraZeneca, F. Hoffmann-La Roche, Merck and Co., Inc., and Valeant Pharmaceutical […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Polycythemia Vera pipeline constitutes 10+ key companies continuously working towards developing 10+ Polycythemia Vera treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Polycythemia Vera Pipeline report embraces in-depth commercial and clinical assessment of the […]
DelveInsight’s, “B-Cell Non-Hodgkin Lymphoma Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in B-Cell Non-Hodgkin Lymphoma pipeline landscape. It covers the B-Cell Non-Hodgkin Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the B-Cell Non-Hodgkin Lymphoma therapeutics assessment by product type, stage, route of administration, […]
Celiac Disease Clinical Trials Celiac Disease companies are Chugai Pharmaceutical, Calypso Biotech, AMYRA Biotech AG, Equillium Bio, ImmunogenX, Amgen, and others. (Albany, United States) Celiac Disease pipeline constitutes 25+ key companies continuously working towards developing 25+ Celiac Disease treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. […]
Sepsis Clinical Trials Sepsis companies are Pharmazz, Shionogi, Octapharma, Seres Therapeutics, Matisse Pharmaceuticals, Inotrem, Beijing Scitech-Mq Pharmaceuticals, AdrenoMed AG, Shaperon, Recce Pharmaceuticals, Tianjin Chase Sun Pharmaceutical, SNIPR Biome, and others. (Albany, United States) Sepsis pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acute On Chronic Liver Failure pipeline constitutes 8+ key companies continuously working towards developing 8+ Acute On Chronic Liver Failure treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Acute On Chronic Liver Failure Pipeline report […]
The Key Non-Cystic Fibrosis Bronchiectasis Companies in the market include – Boehringer Ingelheim, Zambon, Insmed, AstraZeneca, Zambion, The Marcus Foundation, Inc., Chiesi Farmaceutici S.p.A., SolAeroMed Inc., Zambon SpA, Boehringer Ingelheim, Renovion, Inc., Novartis, Alaxia SAS, and others. DelveInsight’s “Non-Cystic Fibrosis Bronchiectasis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the […]
The Key Dry Eye Disease Companies in the market include – Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Dry Eye Disease pipeline products will significantly revolutionize the Dry Eye […]
